Profile data is unavailable for this security.
About the company
Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.
- Revenue in CNY (TTM)2.21bn
- Net income in CNY136.62m
- Incorporated1998
- Employees2.59k
- LocationJoinn Laboratories China Co LtdA5 Rongjing East StreetEconomic-Technological Development AreaBEIJING 100176ChinaCHN
- Phone+86 1 067869582
- Fax+86 1 067869966
- Websitehttps://www.joinnlabs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bio-Thera Solutions Ltd | 792.41m | -377.76m | 8.34bn | 1.17k | -- | 8.55 | -- | 10.52 | -0.9123 | -0.9123 | 1.91 | 2.36 | 0.342 | 1.14 | 5.43 | 679,018.80 | -16.30 | -23.62 | -25.56 | -30.81 | 67.96 | 79.76 | -47.67 | -106.72 | 0.8215 | -51.22 | 0.4147 | -- | 54.86 | -- | 17.87 | -- | -3.78 | -- |
Mabwell Shanghai Bioscience Co Ltd | 153.40m | -1.08bn | 8.49bn | 1.40k | -- | 3.91 | -- | 55.33 | -2.71 | -2.71 | 0.3839 | 5.43 | 0.0333 | 0.0737 | 5.27 | 102,885.50 | -23.65 | -37.61 | -28.84 | -45.95 | 92.64 | 81.54 | -709.97 | -2,112.26 | 1.63 | -243.33 | 0.4853 | -- | 361.03 | 27.88 | -10.28 | -- | 17.35 | -- |
Polaris Group LLC | 14.51m | -422.92m | 9.30bn | -- | -- | 6.11 | -- | 641.07 | -2.57 | -2.57 | 0.0881 | 9.22 | 0.007 | -- | 33.03 | -- | -20.88 | -16.55 | -22.66 | -17.96 | -19.17 | -- | -2,973.29 | -12,960.21 | 9.74 | -- | 0.2065 | -- | 16.18 | -- | -37.05 | -- | 50.45 | -- |
Joinn Laboratories China Co Ltd | 2.21bn | 136.62m | 9.57bn | 2.59k | 75.92 | 1.33 | -- | 4.33 | 0.1847 | 0.1847 | 2.97 | 10.56 | 0.2227 | 0.7454 | 7.65 | -- | 1.31 | 8.99 | 1.58 | 11.07 | 36.70 | 46.76 | 5.86 | 32.01 | 2.54 | 2.57 | 0.0071 | 23.81 | 4.78 | 42.20 | -63.04 | 29.66 | 8.21 | 23.46 |
Keymed Biosciences Inc | 81.48m | -741.48m | 9.60bn | 1.12k | -- | 3.65 | -- | 117.83 | -3.13 | -3.13 | 0.3437 | 10.37 | 0.0207 | 0.3115 | 7.74 | 100,176.60 | -18.86 | -- | -20.96 | -- | 68.65 | -- | -909.38 | -- | 4.83 | -- | 0.2155 | -- | 253.87 | -- | -16.63 | -- | -- | -- |
TYK Medicines Inc | 0.00 | -427.02m | 10.32bn | 144.00 | -- | -- | -- | -- | -1.27 | -1.27 | 0.00 | -3.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -68.75 | -- | -- | -100.00 | -- | -22.97 | -- | -- | -- |
RemeGen Co Ltd | 1.39bn | -1.58bn | 10.61bn | 3.50k | -- | 2.11 | -- | 7.61 | -3.25 | -3.25 | 2.86 | 5.44 | 0.2411 | 0.4413 | 4.03 | 425,192.40 | -27.42 | -18.66 | -35.04 | -23.75 | 77.11 | 81.94 | -113.72 | -102.88 | 1.06 | -31.34 | 0.4737 | -- | 40.16 | 148.65 | -51.30 | -- | 59.07 | -- |
Ascentage Pharma Group International | 901.10m | -359.51m | 10.75bn | 574.00 | -- | 14.05 | -- | 11.93 | -1.37 | -1.37 | 3.42 | 2.68 | 0.2998 | 3.49 | 2.19 | 1,704,590.00 | -11.97 | -44.93 | -16.78 | -57.04 | 96.96 | 87.68 | -39.93 | -976.10 | 1.83 | -6.44 | 0.6865 | -- | 5.85 | 100.76 | -4.84 | -- | 2.82 | -- |
InnoCare Pharma Ltd | 779.05m | -469.88m | 11.01bn | 1.09k | -- | 1.36 | -- | 14.14 | -0.3068 | -0.3068 | 0.5086 | 4.31 | 0.0786 | 0.9875 | 3.19 | 788,964.40 | -4.88 | -13.41 | -6.20 | -15.36 | 85.59 | 85.99 | -62.04 | -172.16 | 3.77 | -- | 0.1667 | -- | 18.09 | 240.36 | 28.80 | -- | 66.20 | -- |
Clarity Pharmaceuticals Ltd | 0.00 | -203.85m | 11.71bn | -- | -- | 16.40 | -- | -- | -0.1541 | -0.1541 | 0.00 | 0.4694 | 0.00 | -- | -- | -- | -36.56 | -- | -39.21 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -72.03 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to Joinn Laboratories China Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Harvest Fund Management Co., Ltd.as of 28 Mar 2024 | 16.32m | 2.59% |
Hwabao WP Fund Management Co., Ltd.as of 28 Mar 2024 | 10.71m | 1.70% |
China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 7.78m | 1.23% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 6.42m | 1.02% |
Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 3.44m | 0.55% |
China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 2.77m | 0.44% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 2.30m | 0.37% |
Tian Hong Asset Management Co., Ltd.as of 31 Dec 2023 | 2.24m | 0.36% |
The Vanguard Group, Inc.as of 04 Sep 2024 | 1.64m | 0.26% |
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 1.45m | 0.23% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.